Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
21.36
+0.58 (2.79%)
At close: Feb 11, 2026, 4:00 PM EST
21.36
0.00 (0.00%)
After-hours: Feb 11, 2026, 4:32 PM EST
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $2.64 billion as of February 11, 2026. Its market cap has increased by 120.63% in one year.
Market Cap
2.64B
Enterprise Value
1.87B
1-Year Change
120.63%
Ranking
Category
Stock Price
$21.36
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $704.52M to $2.64B, an increase of 275.12%. That is a compound annual growth rate of 18.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.64B | -10.37% |
| Dec 31, 2025 | 2.95B | 116.38% |
| Dec 31, 2024 | 1.36B | -4.70% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 2.83B |
| Dyne Therapeutics | 2.80B |
| Tarsus Pharmaceuticals | 2.78B |
| Disc Medicine | 2.78B |
| Immunome | 2.70B |
| Beam Therapeutics | 2.69B |
| Travere Therapeutics | 2.69B |
| Spyre Therapeutics | 2.64B |